Altasciences Featured Content
-
Clinical Trials Without Boundaries: Multi-Site Solutions
8/21/2025
As early-phase trials grow complex, multi-site solutions help you overcome single-site limits—unlocking broader patient access and greater flexibility.
-
Central Nervous System (CNS) Drug Development, Simplified
7/9/2025
Discover a global CNS leader with 200+ studies completed to date and end-to-end drug development expertise—bridging translational gaps and accelerating your path from discovery to delivery.
-
Psychedelics And Entactogens: Challenges Associated With Schedule 1 Therapeutic Development
5/9/2025
Industry experts explore the regulatory challenges of Schedule 1 drug development, including required studies, specialized assessments, and key formulation and manufacturing considerations.
-
Safety Assessment For Ophthalmic Products
2/20/2025
Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.
-
Comprehensive Services For Ophthalmic Drug Development
2/20/2025
To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.
-
The Complexities Of Early Phase Ophthalmic Drug Development
2/20/2025
Navigating the landscape of ophthalmic drug development can be challenging. Check out this scientific journal that outlines potential challenges, and how to overcome them.
-
Factors Affecting Systemic Drug Exposure
1/22/2025
The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.
-
Managing The Complexities Of Glucagon-Like Peptide-1 Receptor Agonist Drug Development
11/20/2024
Dive into the dynamic world of GLP-1 receptor agonists, where we explore the current landscape, the challenges ahead and the complexities of early-phase drug development.
-
Toxicokinetics, Pharmacokinetics, And Pharmacodynamics
11/20/2024
Discover why gathering and analyzing pharmacokinetic (PK) and pharmacodynamic (PD) data is key — from preclinical studies right to clinical trial conduct.
-
Mental Health: 5 Facts About Psychedelics
10/16/2024
As mental health issues surge globally, especially following the COVID-19 pandemic, renewed interest in psychedelic drugs is driving research into their potential therapeutic uses.